Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography

International Journal of Molecular Medicine

Volumn 18, Issue 1, 2006, Pages 27-32

  Kim, Jae Hong ^a   Kim, In Soo ^a   Kwon, Sun Young ^b   Jang, Byeong Churl ^b   Suh, Seong Il ^b   Shin, Dong Hoon ^b   Jeon, Chang Ho ^c   Son, Eun Ik ^a,d   Kim, Sang Pyo ^b,d  

^a Biomedical Science Institute   (South Korea)

^b Keimyung University   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Dongsan Medical Center   (South Korea)

Author keywords

Denaturing high performance liquid chromatography; Mutation; NF2 gene; Sporadic meningioma

Indexed keywords

MERLIN;

ADULT; AGED; ARTICLE; BLOOD; EXON; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MENINGIOMA; METABOLISM; METHODOLOGY; MIDDLE AGED; MISSENSE MUTATION; MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION;

ADULT; AGED; BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FRAMESHIFT MUTATION; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; NEUROFIBROMIN 2; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE DELETION;

EID: 33748207886     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.1.27     Document Type: Article

References (23)

1. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC and Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002. (Pubitemid 34212595)
2. Martuza RL and Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318: 684-688, 1988.
3. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, Jong RD, Parry D, Eldrige R, Aurias A, Delattre O and Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515-521, 1993.
4. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase V, Ambrose C, Munroe D, Bove C, Haines J, Martuza R, MacDonald M, Seizinger B, Short MP, Buckler A and Gusella J: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800, 1993.
5. Bretscher A, Chambers D, Nguyen R and Reczek D: ERMMerlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 16: 113-143, 2000. (Pubitemid 32037502)
6. Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJ, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR and Kley N: Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6: 185-192, 1994.
7. Doco-Fenzy M, Cornillet P, Scherpereel B, Depernet B, Bisiau- Leconte S, Ferre D, Pluot M, Graftiaux JP and Teyssier JR: Cytogenetic changes in 67 cranial and spinal meningiomas: relation to histopathological and clinical pattern. Anticancer Res 13: 845-850, 1993.
8. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP and Rouleau GA: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6: 180-184, 1994.
9. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD and von Deimling A: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningiomas. Am J Pathol 146: 827-832, 1995.
10. Xiao W and Oefner PJ: Denaturing high-performance liquid chromatoraphy: A review. Hum Mutat 17: 439-474, 2001. (Pubitemid 32480082)
11. Szijan I, Rochefort D, Bruder C, Surace E, Machiavelli G, Dalamon V, Cotignola J, Ferreiro V, Campero A, Basso A, Dumanski JP and Rouleau GA: NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH. Neuromol Med 3: 41-52, 2003. (Pubitemid 37070581)
12. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP and Cavenee WK: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546-5551, 1998.
13. O'Donovan MC, Oefner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy C, Speight G, Upadhyaya M, Sommer SS and McGuffin P: Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 52: 44-49, 1998. (Pubitemid 28452169)
14. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN and James CD: Denaturing high-performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 26: 1396-1400, 1998. (Pubitemid 28291612)
15. Dobson-Stone C, Cox RD, Lonie L, Southam L, Fraser M, Wise C, Bernier F, Hodgson S, Porter DE, Simpson AH and Monaco AP: Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses. Eur J Hum Genet 8: 24-32, 2000.
16. Nickerson ML, Weirich G, Zbar B and Schmidt LS: Signature-based analysis of MET proto-oncogene mutations using DHPLC. Hum Mutat 16: 68-76, 2000. (Pubitemid 30447971)
17. Sivakumaran TA, Kucheria K and Oefner PJ: Denaturing high-performance liquid chromatography in the molecular diagnosis of genetic disorders. Curr Sci 84: 291-296, 2003. (Pubitemid 39174833)
18. Sherman LS and Gutmann DH: Merlin: hanging tumor suppression on the Rac. Trends Cell Biol 11: 442-444, 2001. (Pubitemid 33001426)
19. Lekanne Deprez, RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJ, Kley N and Zwarthoff EC: Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54: 1022-1029, 1994.
20. Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS and Huang DP: Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 37: 764-773, 1995.
21. Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA and Maher ER: Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningiomas. J Neurosurg 84: 847-851, 1996. (Pubitemid 26120100)
22. Ueki K, Wen-Bin C, Narita Y, Asai A and Kirino T: Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res 59: 5995-5998, 1999.
23. Evans JJ, Jeun SS, Lee JH, Harwalkar JA, Shoshan Y, Cowell JK and Golubic M: Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas. J Neurosurg 94: 111-117. 2001. (Pubitemid 32799480)